Sector ratings Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
01:09:21 2026-08-25 pm EDT
|
5-day change | 1st Jan Change | ||
| 298.41 USD | -0.06% |
|
+6.70% | +49.33% |
| Aug. 20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| Aug. 20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 14.25B | AA | |||||||
| 51.21B | AAA | |||||||
| 45.35B | - | B | - | - | ||||
| 42.84B | AAA | |||||||
| 42.29B | - | |||||||
| 32.15B | A | |||||||
| 17.31B | BBB | |||||||
| 16.55B | - | - | - | - | ||||
| 14.84B | AA | |||||||
| 13.38B | AAA | |||||||
| 11.94B | A | - | ||||||
| 11.27B | AA | |||||||
| 11.35B | AA | |||||||
| 10.71B | - | BBB | - | - | ||||
| 10.28B | - | B | - | - | ||||
| 10.17B | - | B | - | - | ||||
| 10.01B | BB | - | ||||||
| 10.07B | - | BBB | - | - | ||||
| 10.31B | - | A | - | - | ||||
| 9.1B | AA | - | ||||||
| Average | 19.77B | A | |||||||
| Weighted average by Cap. | A |
Select your edition
All financial news and data tailored to specific country editions
